SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-032144
Filing Date
2024-08-14
Accepted
2024-08-14 16:01:41
Documents
66
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 723977
2 ex31-1.htm EX-31.1 11413
3 ex31-2.htm EX-31.2 11328
4 ex32-1.htm EX-32.1 8334
5 form10-q_001.jpg GRAPHIC 7800
  Complete submission text file 0001493152-24-032144.txt   3913690

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE mtnb-20240630.xsd EX-101.SCH 30493
7 XBRL CALCULATION FILE mtnb-20240630_cal.xml EX-101.CAL 49405
8 XBRL DEFINITION FILE mtnb-20240630_def.xml EX-101.DEF 82286
9 XBRL LABEL FILE mtnb-20240630_lab.xml EX-101.LAB 286605
10 XBRL PRESENTATION FILE mtnb-20240630_pre.xml EX-101.PRE 229275
69 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 486829
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38022 | Film No.: 241207296
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)